U.S. FDA approves Pfizer’s drug to treat eczema

(Reuters) – The U.S. Food and Drug Administration approved Pfizer Inc’s drug Cibinqo to treat eczema, a skin disease, the company said on Friday.

(Reporting by Leroy Leo in Bengaluru; Editing by Arun Koyyur)